At eGenesis, we are committed to ending the global transplant shortage and transforming the treatment of organ failure. We are bringing that vision closer to reality with lead programs in kidney and islet cell transplantation.
Read More: eGenesis Announces IND Clearance for EGEN-2784 in Kidney Transplant and Landmark Patient Updates in Ongoing Expanded Access Study
At eGenesis, we are committed to ending the global transplant shortage and transforming the treatment of organ failure. We are bringing that vision closer to reality with lead programs in kidney and islet cell transplantation.
